CAS: 3027-05-2; 1,4-Diacetylpiperazine-2,5-Dione

该化合物是一种化学化合物,其特点是源自N,N'-二乙基苯基丙烯基丙酸的亚化氢,其特点是其以亚化氢形式呈现的化学化合物,其稳定性一般是白色到白色的固体,以其在水中的溶解性较低而闻名,同时有机溶剂中更易溶解.化合物的功能组包括亚化物和亚化氢,这助长了其再活性,特别是细胞化反应.有机合成中经常使用该化合物,特别是各种衍生物的制作和化合成中.该化合物的稳定性可能受到水分和温度等环境因素的影响,这些环境因素可能导致水解或降解.在处理该物质时,应注意安全防范措施,因为如果吸入或浸入水,可能会对健康造成危害,而且应使用适当的保护设备.

结构式图片

相似化合物

5625-52-5 106-57-0 106-57-0

欧盟法规

ECHA物质C&L通报

合成工艺路线路线简述

    甘氨酸酐 以 Acetic Anhydride (Ac2O),乙酸乙酯 作为反应溶剂,以26.4 G (61%)的收率获得产物1,4-二乙酰基哌嗪-2,5-二酮
    参考文献:Dehydrophenylahistins And Analogs Thereof And The Synthesis Of Dehydrophenylahistins And Analogs Thereof
    标题:Dehydrophenylahistins And Analogs Thereof And The Synthesis Of Dehydrophenylahistins And Analogs Thereof
    摘要:公开了以下结构(i)代表的化合物:制备这种化合物的方法也被公开,其中所述方法包括将二酰基二酮哌嗪与第一醛反应以产生中间化合物;然后将中间化合物与第二醛反应,以产生具有通用结构的化合物类,其中第一醛和第二醛选自氧唑羧醛,咪唑羧醛,苯甲醛,咪唑羧醛衍生物和苯甲醛衍生物组成的群体,从而形成上述化合物,其中r1,R1',R1'',R2,R3,R4,R5和r6,X1和x2,Y,Z,Z1,Z2,Z3和z4可以分别根据附带说明书中的描述进行定义.还公开了用于治疗血管增殖的组合物和方法.

    海关参考信息

    专利信息


    专利号:US-2004030209-A1
    优先权日:2000-11-30
    标 题:Method for the production of alkyl aryl sulphonates
    发明人:NARBESHUBER THOMAS; STEINBRENNER ULRICH; KRACK GERHARD
    摘要:The preparation of alkylaryl compounds takes place by n 1) preparation of a mixture of, on statistical average, predominantly monobranched C 10-14 -olefins by n a) reaction of a C 4 -olefin mixture over a metathesis catalyst for the preparation of an olefin mixture comprising 2-pentene and/or 3-hexene, and optional removal of 2-pentene and/or 3-hexene, followed by dimerization of the resulting 2-pentene and/or 3-hexene over a dimerization catalyst to give a mixture comprising C 10-12 -olefins, and optionally removal of the C 10-12 -olefins, or n b) extraction of predominantly monobranched paraffins from kerosene cuts and subsequent dehydrogenation, or n c) Fischer-Tropsch synthesis of olefins or paraffins, where the paraffins are dehydrogenated, or n d) dimerization of shorter-chain internal olefins, or n e) isomerization of linear olefins or paraffins, where the isomerized paraffins are dehydrogenated, n 2) reaction of the olefin mixture obtained in stage 1) with an aromatic hydrocarbon in the presence of an alkylation catalyst which contains zeolites of the faujasite type.

    专利号:US-7935704-B2
    优先权日:2003-08-01
    标 题 :Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof
    发明人:PALLADINO MICHAEL A; LLOYD GEORGE KENNETH; HAYASHI YOSHIO; NICHOLSON BENJAMIN
    权利人:NEREUS PHARMACEUTICALS INC
    摘要:Compounds represented by the following structure (I) are disclosed: n nas are methods for making such compounds, wherein said methods comprise reacting a diacyldiketopiperazine with a first aldehyde to produce an intermediate compound; and reacting the intermediate compound with a second aldehyde to produce the class of compounds with the generic structure, where the first aldehyde and the second aldehydes are selected from the group consisting of an oxazolecarboxaldeyhyde, imidazolecarboxaldehyde, a benzaldehyde, imidazolecarboxaldehyde derivatives, and benzaldehyde derivatives, thereby forming the above compound wherein R 1 , R 1 ′, R 1 ″, R 2 , R 3 , R 4 , R 5 , and R 6 , X 1 and X 2 , Y, Z, Z 1 , Z 2 , Z 3 , and Z 4 may each be separately defined in a manner consistent with the accompanying description. Compositions and methods for treating vascular proliferation are also disclosed.

    专利号:US-7956058-B2
    优先权日:2002-08-02
    标 题:Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof
    发明人:HAYASHI YOSHIO; PALLADINO JR MICHAEL A; GRODBERG JENNIFER
    权利人:NEREUS PHARMACEUTICALS INC
    摘要:Compounds represented by the following structure (I) are disclosed: n nas are methods for making such compounds, wherein said methods comprise reacting a diacyldiketopiperazine with a first aldehyde to produce an intermediate compound; and reacting the intermediate compound with a second aldehyde to produce the class of compounds with the generic structure, where the first aldehyde and the second aldehydes are selected from the group consisting of an oxazolecarboxaldeyhyde, imidazolecarboxaldehyde, a benzaldehyde, imidazolecarboxaldehyde derivatives, and benzaldehyde derivatives, thereby forming the above compound wherein R 1 , R 1 ′, R 1 ′, R 2 , R 3 , R 4 , R 5 , and R 6 , X 1 and X 2 , Y, Z, Z 1 , Z 2 , Z 3 , and Z 4 may each be separately defined in a manner consistent with the accompanying description. Compositions and methods for treating cancer and fungal infection are also disclosed.

    专利号:US-8993762-B2
    优先权日:2013-03-15
    标题 :Total synthesis of thaxtomin A analogues and their intermediates
    发明人:HUANG HUAZHANG; YAN DONG; XUE ZHIJIE; ZHANG HONGBO
    权利人:MARRONE BIO INNOVATIONS INC; MARRONE BIO INNOVATIONS INC
    摘要:Improved synthetic methods for the production of thaxtomin analogs, particularly thaxtomin A, and intermediates therefore such as substituted tryptophans and in particular, 4-nitro-L-tryptophan, and substituted phenyl acrylic acids are disclosed. Bioassays show that the synthetic thaxtomin A is not significantly different from the natural one in herbicidal activity.

    专利号:US-10434098-B2
    优先权日:2015-06-02
    标 题 :Deuterated dehydrophenylahistin compounds and preparation method thereof and use thereof in preparation of anti-tumor drugs
    发明人:LI WENBAO; SUN TIANWEN; WANG SHIXIAO; ZHAO JIANCHUN; CAI BING; GUAN HUASHI
    权利人:MARINE BIOMEDICAL RES INST QINGDAO CO LTD
    摘要:Provided are a deuterium-substituted dehydrophenylahistin-like compound, preparation method thereof and use in a preparation of antitumor drugs. The deuterium-substituted dehydrophenylahistin-like compound has a structure of general formula (I), and a synthesis method thereof comprises: firstly conducting a condensation reaction of diacetyldiketopiperazine and an aldehyde intermediate a or a deuterated aldehyde compound b to form a heterocyclic compound c or a deuterium-containing heterocyclic compound d, which is then subjected to a condensation reaction with benzaldehyde and a deuterium-substituted benzaldehyde-like compound to form the deuterium-substituted dehydrophenylahistin-like compound. Also provided are a highly effective deuterated aldehyde intermediate with a high deuterium substitution rate and a deuterium-containing heterocycle intermediate, and a synthesis method thereof. An experiment shows that the deuterium-substituted dehydrophenylahistin-like compound provided by the present invention has an effect on tubulin depolymerization and can treat a refractory solid tumor or lymphoma. The present invention provides a method for researching and developing antitumor drugs of the related compound.

    专利号:US-2005197344-A1
    优先权日:2003-08-01
    标题 :Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof
    安庆博曼生物技术有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.bomanbiochem.com
    企业联系电话:0556-5203536👤
    📞安庆博曼生物技术有限公司 ⚠️参考联系方式
    联系人:陈 佳(总经理) 何雪垠(技术总监)
    电话:0556-5203536
    手机:13588048971;18955636051/13365798276
    传真:0556-5203536
    邮箱:sales@bomanbiochem.com;chen@bomanbiochem.com
    通信地址: 安徽省安庆市高新区皇冠路8号
    邮编:
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:安徽省安庆市高新区皇冠路8号
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献

    参考标题:Ir-Catalyzed Double Asymmetric Hydrogenation Of 3,6-Dialkylidene-2,5-Diketopiperazines For Enantioselective Synthesis Of Cyclic Dipeptides
    作者:Yao Ge,Zhaobin Han,Zheng Wang,Kuiling Ding |发布日期:2019.6.5
    摘要:Synthesis Of 6A And Efficient Construction Of Chiral Products 8, 14, And 17 As Well As A 2-Butenyl-Bridged Bicyclic Diketopiperazine 10 And Hydroxydiketopiperazine 11. With An Analogous Achiral Ir Catalyst, The Hydrogenation Of Enantiopure Monohydrogenated Intermediate 7A Gave Cis-6A As The Only Product, Indicating That The Second-Step Hydrogenation Of The Titled Transformation Is A Chiral Substrate Controlled

    合成参考文献


    参考文献:10.1055/s-0033-1340473
    摘要:Liu Y, Liao S, Qin C, Yao P, Li J, Zhou X, Wang J, Huang Z. One-Pot Synthesis of Polysubstituted 3-Amino-2-oxo-2,7-dihydro-1H-azepines. Synthesis. 2014 Jan 02;46(05):621–8. doi: 10.1055/s-0033-1340473.
    参考文献:10.1007/s11696-023-02742-2
    摘要:Chen H, Liu Y, Jiang R, Yu X, Qin M, Gong P. Improved protocol for synthesizing (3Z,6Z)-3-benzylidene-6-[(5-tert-butyl-1H-imidazol-4-yl)methylidene]piperazine-2,5-dione (plinabulin). Chem. Pap. 2023 Apr 08;77(7):3803–10. doi: 10.1007/s11696-023-02742-2.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知